ACTIFUSOR Trademark

Trademark Overview

On Wednesday, September 20, 2023, a trademark application was filed for ACTIFUSOR with the United States Patent and Trademark Office. The USPTO has given the ACTIFUSOR trademark a serial number of 98188941. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 16, 2024. This trademark is owned by Baxter International Inc.. The ACTIFUSOR trademark is filed in the Medical Instrument Products category with the following description:

Pumps for medical purposes, namely, infusion pumps for delivering measured amounts of pharmaceutical solutions parenterally into a patient
actifusor

General Information

Serial Number98188941
Word MarkACTIFUSOR
Filing DateWednesday, September 20, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2024

Trademark Statements

Goods and ServicesPumps for medical purposes, namely, infusion pumps for delivering measured amounts of pharmaceutical solutions parenterally into a patient

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, October 6, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBaxter International Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameBaxter International Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Saturday, September 23, 2023NEW APPLICATION ENTERED
Friday, October 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 8, 2024ASSIGNED TO EXAMINER
Friday, April 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 11, 2024NON-FINAL ACTION WRITTEN
Thursday, April 11, 2024NON-FINAL ACTION E-MAILED
Thursday, April 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

actifusor pumps pharmaceutical solutions parenterally patient amounts delivering medical purposes namely